Reversible Congenital Hypogonadotropic Hypogonadism in Patients with CHD7, FGFR1 or GNRHR Mutations
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Congenital hypogonadotropic hypogonadism (HH) is a rare cause for delayed or absent puberty. These patients may recover from HH spontaneously in adulthood. To date, it is not possible to predict who will undergo HH reversal later in life. Herein we investigated whether Finnish patients with reversal of congenital hypogonadotropic hypogonadism (HH) have common phenotypic or genotypic features. METHODS AND FINDINGS: Thirty-two male HH patients with anosmia/hyposmia (Kallmann Syndrome, KS; n = 26) or normal sense of smell (nHH; n = 6) were enrolled (age range, 18-61 yrs). The patients were clinically examined, and reversal of HH was assessed after treatment withdrawal. KAL1, FGFR1, FGF8, PROK2, PROKR2, CHD7, WDR11, GNRHR, GNRH1, KISS1R, KISS1, TAC3, TACR3, and LHβ were screened for mutations. Six HH patients (2 KS, 4 nHH) were verified to have reversal of HH. In the majority of cases, reversal occurred early in adulthood (median age, 23 yrs; range, 21-39 yrs). All had spontaneous testicular growth while on testosterone replacement therapy (TRT). One nHH subject was restarted on TRT due to a decline in serum T. Two reversal variants had a same GNRHR mutation (R262Q), which was accompanied by another GNRHR mutation (R139H or del309F). In addition, both of the KS patients had a mutation in CHD7 (p.Q51X) or FGFR1 (c.91+2T>A). CONCLUSIONS: Considerable proportion of patients with HH (8% of KS probands) may recover in early adulthood. Spontaneous testicular enlargement during TRT was highly suggestive for reversal of HH. Those with the GNRHR mutation R262Q accompanied by another GNRHR mutation may be prone to reversal, although even patients with a truncating mutation in CHD7 or a splice-site mutation in FGFR1 can recover. We recommend that all adolescents and young adults with congenital HH should be informed on the possibility of reversal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“CHD7 rare variants have previously been associated with milder reproductive phenotypes such as self-limiting delayed puberty (58) and reversal of hypogonadotropic hypogonadism (59).”
From Functional Hypogonadotropic Hypogonadism in Men: Underlying Neuroendocrine Mechanisms and Natural History (2019) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CHD7 cooperates with PBAF to control multipotent neural crest formation
Bajpai, R., Chen, D. A., Rada-Iglesias, A., Zhang, J., Xiong, Y., Helms, J., Chang, C.-P., Zhao, Y., Swigut, T., & Wysocka, J. (2010) · Nature · doi:10.1038/nature08733 · Cited by 616 · cited 1×
“Alternatively, CHD7 is one of the key genes for the formation of cranial neural crest [38], which has been suggested to be the source of ,30% of GnRH neurons in mice [39].”
BackgroundSchwanzel-Fukuda, M., Bick, D., & Pfaff, D. W. (1989) · Molecular Brain Research · doi:10.1016/0169-328x(89)90076-4 · Cited by 616
de Roux, N., Young, J., Misrahi, M., Genet, R., Chanson, P., Schaison, G., & Milgrom, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372205 · Cited by 518
Seminara, S. B., Hayes, F. J., & Crowley, W. F. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0344 · Cited by 414
Reversal of Idiopathic Hypogonadotropic Hypogonadism
Raivio, T., Falardeau, J., Dwyer, A., Quinton, R., Hayes, F. J., Hughes, V. A., Cole, L. W., Pearce, S. H., Lee, H., Boepple, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066494 · Cited by 413 · cited 4×
“However, up to 10% of HH patients may undergo reversal of hypogonadotropism and some of them even attain normal sperm count [6].”
BackgroundResultInfluentialSelf-citationKim, H.-G., Kurth, I., Lan, F., Meliciani, I., Wenzel, W., Eom, S. H., Kang, G. B., Rosenberger, G., Tekin, M., Ozata, M., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.09.005 · Cited by 338
Gianetti, E., Tusset, C., Noel, S. D., Au, M. G., Dwyer, A. A., Hughes, V. A., Abreu, A. P., Carroll, J., Trarbach, E., Silveira, L. F. G., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2320 · Cited by 294 · cited 1×
“For example, reversal variants have heterogeneous genetic background and may harbor mutation(s) in KAL1 [18], FGFR1 [16,20], PROK2 [19], GNRHR [15,17], and TAC3/TACR3 [21].”
BackgroundBlake, K. D., & Prasad, C. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-34 · Cited by 278
Forni, P. E., Taylor-Burds, C., Melvin, V. S., Williams, T., & Wray, S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6087-10.2011 · Cited by 224 · cited 1×
“Alternatively, CHD7 is one of the key genes for the formation of cranial neural crest [38], which has been suggested to be the source of ,30% of GnRH neurons in mice [39].”
BackgroundJongmans, M., Van Ravenswaaij‐Arts, C., Pitteloud, N., Ogata, T., Sato, N., Claahsen‐van der Grinten, H., Van Der Donk, K., Seminara, S., Bergman, J., Brunner, H., et al. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01107.x · Cited by 212 · cited 2×
“The latter are suggested to represent a mild end of CHARGE phenotypic spectrum due to overlapping features of these syndromes such as hypogonadism, anosmia, cleft lip and palate, hearing impairment, and semicircular canal hypoplasia [32,33].”
Background
Research works printed but not linked: 1
- Rezvani I DiGeorge A Rutano J Snyder P 1975 Delayed puberty and anosmia; coincidence or Kallmann variant? Pediatr Res 9 224
Cited by
Boehm, U., Bouloux, P.-M., Dattani, M. T., de Roux, N., Dodé, C., Dunkel, L., Dwyer, A. A., Giacobini, P., Hardelin, J.-P., Juul, A., et al. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.112 · Cited by 874
Self-citationPaediatric and adult-onset male hypogonadism
Salonia, A., Rastrelli, G., Hackett, G., Seminara, S. B., Huhtaniemi, I. T., Rey, R. A., Hellstrom, W. J. G., Palmert, M. R., Corona, G., Dohle, G. R., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0087-y · Cited by 286
Sidhoum, V. F., Chan, Y.-M., Lippincott, M. F., Balasubramanian, R., Quinton, R., Plummer, L., Dwyer, A., Pitteloud, N., Hayes, F. J., Hall, J. E., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2809 · Cited by 163
Valdes-Socin, H., Rubio Almanza, M., Tomé Fernández-Ladreda, M., Debray, F. G., Bours, V., & Beckers, A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00109 · Cited by 127
“described in 2012, a KS patient with a truncating CHD7 mutation that underwent a reversal of central hypogonadism after therapy discontinuation (15).”
BackgroundVarimo, T. J., Miettinen, P. J., Känsäkoski, J., Raivio, T., & Hero, M. T. (2016) · Human Reproduction · doi:10.1093/humrep/dew294 · Cited by 115
“Overall, 11 boys and 5 girls were diagnosed with CHH and 12 of them were screened for CHH genes (Laitinen et al., 2011, 2012; Hero et al., 2012, 2015; Varimo et al., 2016).”
BackgroundSelf-citationRohayem, J., Nieschlag, E., Kliesch, S., & Zitzmann, M. (2015) · Andrology · doi:10.1111/andr.12088 · Cited by 84
“In contrast, HH, if not reversible in rare cases (Laitinen et al., 2012), will require lifelong hormonal replacement.”
BackgroundMutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadism
Känsäkoski, J., Fagerholm, R., Laitinen, E., Vaaralahti, K., Hackman, P., Pitteloud, N., Raivio, T., & Tommiska, J. (2014) · Pediatric Research · doi:10.1038/pr.2014.23 · Cited by 80
Self-citationMANAGEMENT OF ENDOCRINE DISEASE: Reversible hypogonadotropic hypogonadism
Dwyer, A. A., Raivio, T., & Pitteloud, N. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1033 · Cited by 80
Self-citationTrue, C., Nasrin Alam, S., Cox, K., Chan, Y.-M., & Seminara, S. B. (2015) · Endocrinology · doi:10.1210/en.2014-1862 · Cited by 66
Francou, B., Paul, C., Amazit, L., Cartes, A., Bouvattier, C. M., Albarel, F., Maiter, D. M., Chanson, P., Trabado, S., Brailly‐Tabard, S., et al. (2016) · Human Reproduction · doi:10.1093/humrep/dew073 · Cited by 64
“This is in keeping with the literature, as no cases of reversible CHH have been reported in patients with biallelic KISS1R mutations (Quinton et al., 1999; Raivio et al., 2007; Sinisi et al., 2008; Laitinen et al., 2012; Sidhoum et al., 2014).”
ResultBeneduzzi, D., Trarbach, E. B., Min, L., Jorge, A. A. L., Garmes, H. M., Renck, A. C., Fichna, M., Fichna, P., Arantes, K. A., Costa, E. M. F., et al. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.05.044 · Cited by 59
Guidelines in CHARGE syndrome and the missing link: Cranial imaging
de Geus, C. M., Free, R. H., Verbist, B. M., Sival, D. A., BLAKE, K. D., Meiners, L. C., & van Ravenswaaij‐Arts, C. M. A. (2017) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31593 · Cited by 49
Genetic evaluation of male infertility.
Wosnitzer, M. S. (2014) · PubMed Central · doi:10.3978/j.issn.2223-4683.2014.02.04 · Cited by 59
“Treatment includes hormone replacement therapy based on deficiency (36,37).”
BackgroundReproductive endocrine phenotypes relating to CHD7 mutations in humans
Balasubramanian, R., & Crowley, W. F. (2017) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31585 · Cited by 51
“While recovery of the HPG axis has not been reported in CHARGE patients with CHD7mutations, a recent report identified a patient with IHH and CHD7 truncatingmutationwhoexperiencedspontaneous reversal ofhis IHH (Laitinen et al., 2012).”
ResultGenetic testing and counselling for male infertility
Krausz, C. G., & Chianese, C. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000058 · Cited by 46
“A relatively newly identified feature of this disease is the presence of reversible cases, which represent about 10% of all cHH and does not seem to correlate with specific gene defects [14,16,17].”
BackgroundZhou, C., Niu, Y., Xu, H., Li, Z., Wang, T., Yang, W., Wang, S., Wang, D. W., & Liu, J. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.04.010 · Cited by 46
Dwyer, A. A., Chavan, N. R., Lewkowitz-Shpuntoff, H., Plummer, L., Hayes, F. J., Seminara, S. B., Crowley, W. F., Pitteloud, N., & Balasubramanian, R. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02697 · Cited by 41
“Indeed,CHD7 rare variants have previously been associated with milder reproductive phenotypes such as self-limiting delayed puberty (58) and reversal of hypogonadotropic hypogonadism (59).”
BackgroundPuberty in Non-human Primates and Man
Plant, T. M., Terasawa, E., & Witchel, S. F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00032-6 · Cited by 43
Louden, E. D., Poch, A., Kim, H., Ben‐Mahmoud, A., Kim, S., & Layman, L. C. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111334 · Cited by 38
Men, M., Wu, J., Zhao, Y., Xing, X., Jiang, F., Zheng, R., & Li, J. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.08.069 · Cited by 28
Health‐related quality of life in male patients with congenital hypogonadotropic hypogonadism
Varimo, T. J., Hero, M. T., Laitinen, E., Sintonen, H., & Raivio, T. (2014) · Clinical Endocrinology · doi:10.1111/cen.12701 · Cited by 27
Self-citationTommiska, J., Jørgensen, N., Christiansen, P., Juul, A., & Raivio, T. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04493.x · Cited by 26
Self-citationGenetics of congenital hypogonadotropic hypogonadism in Denmark
Tommiska, J., Känsäkoski, J., Christiansen, P., Jørgensen, N., Lawaetz, J. G., Juul, A., & Raivio, T. (2014) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2014.04.002 · Cited by 29
Self-citationChildhood growth in boys with congenital hypogonadotropic hypogonadism
Varimo, T. J., Hero, M. T., Laitinen, E., Miettinen, P. J., Tommiska, J., Känsäkoski, J., Juul, A., & Raivio, T. (2015) · Pediatric Research · doi:10.1038/pr.2015.278 · Cited by 25
Self-citationKohva, E., Huopio, H., Hero, M. T., Miettinen, P. J., Vaaralahti, K., Sidoroff, V., Toppari, J., & Raivio, T. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00225 · Cited by 23
Self-citationHietamäki, J., Hero, M. T., Holopainen, E., Känsäkoski, J., Vaaralahti, K., Iivonen, A.-P., Miettinen, P. J., & Raivio, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188750 · Cited by 23
Self-citationAoyama, K., Mizuno, H., Tanaka, T., Togawa, T., Negishi, Y., Ohashi, K., Hori, I., Izawa, M., Hamajima, T., & Saitoh, S. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2017-0035 · Cited by 22
“Additionally, KS12 with a CHD7 mutation presented mild phenotypes of relatively higher basal gonadotropin levels, which were consistent with a previous report [8].”
ResultPediatric and adolescent gynecology
Bieber, E. J., Sanfilippo, J. S., Horowitz, I., & Shafi, M. I. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.035 · Cited by 19
Dwyer, A. A., McDonald, I. R., Cangiano, B., Giovanelli, L., Maione, L., Silveira, L. F. G., Raivio, T., Latronico, A. C., Young, J., Quinton, R., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00028-7 · Cited by 20
Self-citationSex Steroid and Gonadotropin Treatment in Male Delayed Puberty
Howard, S. R., & Dunkel, L. (2015) · Endocrine development · doi:10.1159/000438891 · Cited by 18
Onset and progression of puberty in Klinefelter syndrome
Tanner, M., Miettinen, P. J., Hero, M. T., Toppari, J., & Raivio, T. (2021) · Clinical Endocrinology · doi:10.1111/cen.14588 · Cited by 19
“3–45 nmol/L.(32) Gonadotropin levels were measured with im-”
MethodSelf-citationCentral Hypogonadotropic Hypogonadism: Genetic Complexity of a Complex Disease
Marino, M., Moriondo, V., Vighi, E., Pignatti, E., & Simoni, M. (2014) · International Journal of Endocrinology · doi:10.1155/2014/649154 · Cited by 18
Kałużna, M., Budny, B., Rabijewski, M., Kałużny, J., Dubiel, A., Trofimiuk–Müldner, M., Wrotkowska, E., Hubalewska–Dydejczyk, A., Ruchała, M., & Ziemnicka, K. (2021) · Genes · doi:10.3390/genes12060868 · Cited by 18
Kallmann syndrome in a patient with Weiss–Kruszka syndrome and a de novo deletion in 9q31.2
Iivonen, A.-P., Kärkinen, J., Yellapragada, V., Sidoroff, V., Almusa, H., Vaaralahti, K., & Raivio, T. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1387 · Cited by 16
“To further probe the possible role of PALM2AKAP2 in KS, we screened the coding exons and exon-intron boundaries of both PALM2 and AKAP2 in 16 Finnish KS patients without mutations in established KS-causing genes (19, 20).”
Self-citationReview of human genetic and clinical studies directly relevant to GnRH signalling
Seminara, S. B., & Topaloglu, A. K. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13080 · Cited by 18
Genetics of congenital olfactory dysfunction: a systematic review of the literature
Deller, M., Gellrich, J., Lohrer, E. C., & Schriever, V. A. (2022) · Chemical Senses · doi:10.1093/chemse/bjac028 · Cited by 16
Puberty and its disorders in the male
Palmert, M. R., Dunkel, L., & Witchel, S. F. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00026-3 · Cited by 18
The loss of scents: Do defects in olfactory sensory neuron development underlie human disease?
Whitlock, K. E. (2015) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21094 · Cited by 17
Kallman syndrome and central non-obstructive azoospermia
Thakker, S. S., Persily, J. B., & Najari, B. B. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101475 · Cited by 15
Hypogonadotropic Hypogonadism due to Novel FGFR1 Mutations
Akkuş, G., Kotan, L. D., Durmaz, E., Mengen, E., Turan, İ., Ulubay, A., Gürbüz, F., Yüksel, B., Tetıker, T., & Topaloglu, A. K. (2017) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.3908 · Cited by 16
“Six of the patients with splicing mutations (75%) were male (10,13,14).”
BackgroundAbbara, A., Koysombat, K., Phylactou, M., Eng, P. C., Clarke, S. A., Comninos, A. N., Yang, L. Y., Izzi‐Engbeaya, C. N., Hanassab, S., Smith, N. T., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1076984 · Cited by 13
“CHH is a genetic trait causing impaired hypothalamic gonadotrophin releasing hormone (GnRH) neuronal migration, leading to lack or deficient number of GnRH neurons; or function, as result of disturbed secretion or action of GnRH, or both (9).”
BackgroundGenetic Analysis of Patients with Congenital Hypogonadotropic Hypogonadism: A Case Series
Cannarella, R., Gusmano, C., Condorelli, R. A., Bernini, A., Kaftalli, J., Maltese, P. E., Paolacci, S., Dautaj, A., Marceddu, G., Bertelli, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087428 · Cited by 12
“Heterozygous variants in the DUSP6 gene have been associated with patients with cHH in the literature [37,38], which increases its likelihood of playing an etiopathogenic role in the patient’s phenotype here described.”
BackgroundChung, W. C. J., & Tsai, P. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1166132 · Cited by 11
Varimo, T. J., Hero, M. T., Känsäkoski, J., Vaaralahti, K., Matikainen, N., & Raivio, T. (2015) · Clinical Endocrinology · doi:10.1111/cen.12851 · Cited by 10
Self-citationWitchel, S. F., & Plant, T. M. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00018-4 · Cited by 13
Puberty and Its Disorders in the Male
Palmert, M. R., Chan, Y.-M., & Dunkel, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00018-x · Cited by 18
Childhood growth of females with K allmann syndrome and FGFR 1 mutations
Hero, M. T., Laitinen, E., Varimo, T. J., Vaaralahti, K., Tommiska, J., & Raivio, T. (2014) · Clinical Endocrinology · doi:10.1111/cen.12504 · Cited by 11
Self-citationA novel CHD7 mutation in an adolescent presenting with growth and pubertal delay
Antoniou, M.-C., Bouthors, T., Xu, C., Phan-Hug, F., Elowe-Gruau, É., Stoppa‐Vaucher, S., van der Sloot, A. M., Acierno, J. S., Cassatella, D., Richard, C., et al. (2019) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2019.24.1.49 · Cited by 6
CHD7 missense variants and clinical characteristics of Chinese males with infertility
Li, L., Wang, R., Yu, Y., Zhang, H., Jiang, Y., Yang, X., & Liu, R. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1372 · Cited by 7
“Therefore, our patients with low testosterone may also benefit from TRT treatment.”
BackgroundInfluentialDanda, V. S. R., Paidipally, S. R., Verepula, M., Lodha, P., Thaduri, K. R., Konda, C., & Ruhi, A. (2020) · Journal of Reproduction & Infertility · doi:10.18502/jri.v22i1.4994 · Cited by 6
“Considering all reports in the literature, mutations in GNRHR appear to be the leading genetic causes among cases of reversal (32, 33).”
BackgroundMolecular genetics and phenotypic features of congenital isolated hypogonadotropic hypogonadism
Kokoreva, K., Чугунов, І., & Bezlepkina, O. B. (2021) · Problems of Endocrinology · doi:10.14341/probl12787 · Cited by 6
GNRHR-related central hypogonadism with spontaneous recovery – case report
Schweiger, D. Š., Povše, M. D., Podkrajšek, K. T., Battelino, T., & Stefanija, M. A. (2022) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-022-01377-5 · Cited by 5
“A patient with the same combination of GNRHR variants, as identified in our patient, had a reversal of CHH after hormone replacement therapy was discontinued, similarly as in our patient, but after nine years of spontaneous function, he experienced a relapse of CHH [22].”
ResultTACkling NKB’s Role in Puberty
Angell, A. E., & Steiner, R. A. (2015) · Endocrinology · doi:10.1210/en.2015-1158 · Cited by 5
Reversal of idiopathic hypogonadotropic hypogonadism in a Chinese male cohort
Sun, T., Xu, W., Chen, Y., Niu, Y., Wang, T., Wang, S., Xu, H., & Liu, J. (2022) · Andrologia · doi:10.1111/and.14583 · Cited by 4
“In past decades, a growing number of reports of reversible IHH have emerged, which challenges the traditional understanding of lifelong therapy (Laitinen et al., 2012; Mao et al., 2015; Raivio et al., 2007; Sidhoum et al., 2014).”
BackgroundInfluentialWang, X.-L., Wang, D. D., Gu, J. Q., Zhang, N., & Shan, Z. (2014) · Genetics and Molecular Research · doi:10.4238/2014.november.11.12 · Cited by 6
Varimo, T. J., Hero, M. T., Känsäkoski, J., Vaaralahti, K., Matikainen, N., & Raivio, T. (2016) · Clinical Endocrinology · doi:10.1111/cen.13027 · Cited by 4
Self-citationCHARGE syndrome and Kallmann syndrome: are the two genetically related?
Raivio, T. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.53 · Cited by 3
Self-citationScreening for mutations in selected miRNA genes in hypogonadotropic hypogonadism patients
Iivonen, A.-P., Känsäkoski, J., Vaaralahti, K., & Raivio, T. (2019) · Endocrine Connections · doi:10.1530/ec-19-0080 · Cited by 3
Self-citationComment on reversal of hypogonadotropic hypogonadism in a Chinese cohort
Raivio, T., & Dwyer, A. A. (2015) · Asian Journal of Andrology · doi:10.4103/1008-682x.151399 · Cited by 3
Self-citationReversal of Congenital Hypogonadotropic Hypogonadism
Dwyer, A. A., & Stamou, M. I. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf610 · Cited by 2
Next-generation sequencing approach in the diagnosis of delayed puberty
Saengkaew, T., & Howard, S. R. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.05.003 · Cited by 2
WDR11 Mutations as A Potential Player of Idiopathic Hypogonadotropic Hypogonadism
Imai, A. (2020) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2020.28.004662 · Cited by 2
“A large analysis of 32 reversible IHH patients [18] shows that 2 normosmia male patients carry GNRHR mutation accompanied by another GNRHR mutation and 2 anosmia patients have mutation in CHD7 or FGFR1.”
BackgroundPubertät und Pubertätsstörungen
Heger, S., & Hiort, O. (2014) · Springer eBooks · doi:10.1007/978-3-642-41866-2_67 · Cited by 2
Delayed puberty and primary amenorrhea
Yu, C., & Rosenfield, R. L. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.037 · Cited by 2
Nistal, M., Paniagua, R., González‐Peramato, P., & Reyes‐Múgica, M. (2016) · Pediatric and Developmental Pathology · doi:10.2350/16-04-1810-pb.1 · Cited by 2
“Reversal of congenital hypogonadotropic hypogonadism has been observed in 10% of the patients who are treated [106].”
BackgroundReversible Kallmann Syndrome: Rare Yet Real
Soumya, S. L., Cherian, K. E., Kapoor, N., & Paul, T. V. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_199_19 · Cited by 2
Stimulation of Spermatogenesis in Hypogonadotropic Men
Rohayem, J., & Nieschlag, E. (2017) · Springer eBooks · doi:10.1007/978-3-319-53298-1_20 · Cited by 6
Mutations of the Gonadotropin-Releasing Hormone Receptor Gene
Ulloa‐Aguirre, A., Zariñán, T., & Lira-Albarrán, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.04015-0 · Cited by 2
Genetic Basis and Heterogeneity of Congenital Hypogonadotropic Hypogonadism
Silveira, L. F. G., Seraphim, C. E., & Latronico, A. C. (2025) · Seminars in Reproductive Medicine · doi:10.1055/a-2806-2848 · Cited by 2
Human Genetics of GnRH Neuron Function
Topaloglu, A. K., & Kotan, L. D. (2018) · Wiley eBooks · doi:10.1002/9781119233275.ch17 · Cited by 1
Therapie des hypothalamisch und hypophysär bedingten Hypogonadismus
Rohayem, J., & Nieschlag, E. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-61901-8_38 · Cited by 1
Treatment of Hypogonadism of Hypothalamic or Pituitary Origin
Rohayem, J., & Nieschlag, E. (2023) · Springer eBooks · doi:10.1007/978-3-031-31574-9_38 · Cited by 1
Molecular Genetics of Kallmann Syndrome and Constitutional delay of growth and puberty in Finland
Vaaralahti, K. (2014) · Helda - University of Helsinki Institutional Repository · Cited by 1
Self-citationBeneduzzi, D. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2013.tde-02012014-165016
Congenital Hypogonadotropic Hypogonadism
Winters, S. J. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2059-4_34
Management of delayed puberty in boys: tips and tricks
Abdel‐Hamid, I. A. (2016) · Human Andrology · doi:10.1097/01.xha.0000479440.81161.a2
Male Puberty: What Is Normal and Abnormal?
Hansen, D. W., & Fuqua, J. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_5
Central Hypogonadism in the Male: Physiopathology, Diagnosis and Treatment
Rohayem, J., & Nieschlag, E. (2017) · Endocrinology · doi:10.1007/978-3-319-38681-2_10-1
Das GnRHR-Gen, seine Mutationen und deren Manifestation
Bullerdiek, J., & Bock-Steinweg, U. (2020) · Der Gynäkologe · doi:10.1007/s00129-020-04631-1
“Die ambesten bekannte klinischeManifestation der GnRHR-Mutationen ist in beiden Geschlechtern ein kompletter oder partieller idiopathischer kongenitaler hypogonadotroper Hypogonadismus (IHH), der imGegensatz zumKallmannSyndrom nicht von einer Anosmie begleitet ist [8, 15, 72, 76, 77].”
BackgroundInfluentialDelayed Puberty and Hypogonadism, Male☆
Styne, D. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.04008-3
Pubertät und Pubertätsstörungen
Heger, S., & Hiort, O. (2020) · Springer Reference Medizin · doi:10.1007/978-3-642-54671-6_91-2
Pubertät und Pubertätsstörungen
Heger, S., & Hiort, O. (2015) · Springer eBooks · doi:10.1007/978-3-642-54671-6_91-1 · Cited by 1
Pubertät und Pubertätsstörungen
Heger, S., & Hiort, O. (2020) · Springer Reference Medizin · doi:10.1007/978-3-662-60300-0_91
Central Hypogonadism in the Male: Physiopathology, Diagnosis, and Treatment
Rohayem, J., & Nieschlag, E. (2018) · Endocrinology · doi:10.1007/978-3-319-44444-4_10
Therapie des hypothalamisch und hypophysär bedingten Hypogonadismus
Rohayem, J., & Nieschlag, E. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-61904-9_38-1
Male Puberty: What Is Normal and Abnormal?
Hansen, D. W., & Fuqua, J. S. (2023) · Springer eBooks · doi:10.1007/978-3-031-31501-5_5
Mixed hypogonadism: a neglected combined form of hypogonadism
Zhang, R., Yu, B., Wang, X., Nie, M., Ma, W., Ji, W., Huang, Q., Zhu, Y., Sun, B., Zhang, J., et al. (2023) · Endocrine · doi:10.1007/s12020-023-03532-2
Mutations of the gonadotropin-releasing hormone receptor gene
Ulloa‐Aguirre, A., Zariñán, T., Lira-Albarrán, S., & Carranza, S. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00104-7
Männliche Pubertät: Was ist normal und was ist abnormal?
Hansen, D. W., & Fuqua, J. S. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_5
Male hypogonadism for gynecologists
Valdes-Socin, H. G. (2023) · ORBi (University of Liège)
VALDES SOCIN, H. G., Libioulle, C., DEBRAY, F.-G., Dideberg, V., Bours, V., & BECKERS, A. (2018) · ORBi (University of Liège)
Testosterone and Cardiovascular Health in man
VALDES SOCIN, H. G. (2019) · ORBi (University of Liège)
Le syndrome de Kallmann: un vieux syndrome revisité par la génétique
VALDES SOCIN, H. G., & Libioulle, C. (2018) · ORBi (University of Liège)
Male hypogonadism: diagnosis and treatment
VALDES SOCIN, H. G. (2016) · ORBi (University of Liège)
Primary amenorrhea: the point of vue of the endocrinologist
VALDES SOCIN, H. G. (2016) · ORBi (University of Liège)
Bach, M. Y., Hagin, R., Levy, B., Délot, E. C., Vilain, E. J. N., Kępczyński, Ł., Botvinik, A., Mory, A., Amir, Y., Kałużewski, T., et al. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag234
Metadata
- Authors
- Laitinen, E.-M., Tommiska, J., Sane, T., Vaaralahti, K., Toppari, J., & Raivio, T.
- Affiliations
- University of Helsinki (FI)
- Helsinki University Hospital (FI)
- University of Turku (FI)
- Corresponding author
- Raivio, Taneli
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-06-19
- Volume
- 7
- Issue
- 6
- Pages
- e39450
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3378565
- OpenAlex
- W1982199134
- Cited by
- 89
- References
- 39
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 6 · 2022: 5 · 2021: 7 · 2020: 8 · 2019: 6 · 2018: 4 · 2017: 7 · 2016: 8 · 2015: 14 · 2014: 14 · 2013: 3 · 2012: 2
- FWCI
- 12.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Työväentutkimus Vuosikirja (submittedVersion)
- Funders
- Helsingin Yliopisto
- Helsingin ja Uudenmaan Sairaanhoitopiiri
- Suomen Kulttuurirahasto
- Emil Aaltosen Säätiö
- Lastentautien Tutkimussäätiö
- Helsingin Yliopiston Tiedesäätiö
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- congenital hypogonadotropic hypogonadism, Kallmann syndrome, anosmia, CHD7 mutations, FGFR1 mutation, testosterone replacement therapy, puberty onset, Finnish patients
- MeSH terms
- Adolescent, Adult, DNA Helicases, DNA-Binding Proteins, Genotype, Humans, Hypogonadism, Male, Mutation, Phenotype, Receptors, LHRH, Kallmann Syndrome, Hormone Replacement Therapy, Receptor, Fibroblast Growth Factor, Type 1, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.